Company
Semnur Pharmaceuticals, Inc. (SMNR)
Standardized SEC financial data for Semnur Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001913577 · OTC · Pharmaceutical Preparations.
Operating margin
-320.8%
Net margin
-320.8%
Revenue growth (YoY)
0.0%
Return on equity
773.1%
Free cash flow
-$5.9M
Current ratio
0.06×
EPS (diluted)
$-0.78
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2023 | FY2023 | FY2024 | FY2024 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | $50.0M | $50.0M | — | — |
| R&D expense |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $820K | $204K | — | $12K | — | $20K |
| Total current assets |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$426K | -$633K | -$4.9M | -$5.9M |
| Investing cash flow | -$84.2M | $39.7M | $43.4M | — |
Get SMNR data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/SMNR/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/SMNR/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"